(2S,3R,4R,6R)-4-[hydroxy(methyl)amino]-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
| Internal ID | 01406f06-7ce3-4a56-aae8-988a36f5510f |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | (2S,3R,4R,6R)-4-[hydroxy(methyl)amino]-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one |
| SMILES (Canonical) | CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)O)OC |
| SMILES (Isomeric) | C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)O)OC |
| InChI | InChI=1S/C28H26N4O4/c1-28-26(35-3)19(30(2)34)12-20(36-28)31-17-10-6-4-8-14(17)22-23-16(13-29-27(23)33)21-15-9-5-7-11-18(15)32(28)25(21)24(22)31/h4-11,19-20,26,34H,12-13H2,1-3H3,(H,29,33)/t19-,20-,26-,28+/m1/s1 |
| InChI Key | GNPBRYWPIIHXSV-BXILDPBISA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C28H26N4O4 |
| Molecular Weight | 482.50 g/mol |
| Exact Mass | 482.19540532 g/mol |
| Topological Polar Surface Area (TPSA) | 80.90 Ų |
| XlogP | 3.20 |
| Atomic LogP (AlogP) | 4.46 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 2 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6364 | 63.64% |
| Caco-2 | - | 0.6725 | 67.25% |
| Blood Brain Barrier | - | 0.5750 | 57.50% |
| Human oral bioavailability | + | 0.5429 | 54.29% |
| Subcellular localzation | Lysosomes | 0.3327 | 33.27% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8677 | 86.77% |
| OATP1B3 inhibitior | + | 0.9344 | 93.44% |
| MATE1 inhibitior | - | 0.7400 | 74.00% |
| OCT2 inhibitior | - | 0.7109 | 71.09% |
| BSEP inhibitior | + | 0.9568 | 95.68% |
| P-glycoprotein inhibitior | + | 0.8025 | 80.25% |
| P-glycoprotein substrate | + | 0.8874 | 88.74% |
| CYP3A4 substrate | + | 0.7232 | 72.32% |
| CYP2C9 substrate | - | 0.6219 | 62.19% |
| CYP2D6 substrate | - | 0.8861 | 88.61% |
| CYP3A4 inhibition | + | 0.5590 | 55.90% |
| CYP2C9 inhibition | - | 0.7209 | 72.09% |
| CYP2C19 inhibition | - | 0.7049 | 70.49% |
| CYP2D6 inhibition | - | 0.8572 | 85.72% |
| CYP1A2 inhibition | - | 0.8006 | 80.06% |
| CYP2C8 inhibition | + | 0.6783 | 67.83% |
| CYP inhibitory promiscuity | - | 0.6319 | 63.19% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8200 | 82.00% |
| Carcinogenicity (trinary) | Non-required | 0.5629 | 56.29% |
| Eye corrosion | - | 0.9841 | 98.41% |
| Eye irritation | - | 0.9683 | 96.83% |
| Skin irritation | - | 0.7685 | 76.85% |
| Skin corrosion | - | 0.9304 | 93.04% |
| Ames mutagenesis | + | 0.6846 | 68.46% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6676 | 66.76% |
| Micronuclear | + | 0.8100 | 81.00% |
| Hepatotoxicity | + | 0.6289 | 62.89% |
| skin sensitisation | - | 0.8544 | 85.44% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | + | 0.5156 | 51.56% |
| Acute Oral Toxicity (c) | III | 0.5665 | 56.65% |
| Estrogen receptor binding | + | 0.7414 | 74.14% |
| Androgen receptor binding | + | 0.6704 | 67.04% |
| Thyroid receptor binding | + | 0.5918 | 59.18% |
| Glucocorticoid receptor binding | + | 0.7714 | 77.14% |
| Aromatase binding | + | 0.7407 | 74.07% |
| PPAR gamma | + | 0.7028 | 70.28% |
| Honey bee toxicity | - | 0.7024 | 70.24% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
| Fish aquatic toxicity | - | 0.4904 | 49.04% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 99.28% | 81.14% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.71% | 91.11% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 98.57% | 80.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.55% | 96.09% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.44% | 85.14% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 97.68% | 80.71% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 97.47% | 84.49% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 97.31% | 85.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.64% | 95.56% |
| CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 | 96.64% | 94.29% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 96.50% | 88.81% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 96.36% | 95.64% |
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 | 96.34% | 90.48% |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 | 95.86% | 96.64% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 95.81% | 83.10% |
| CHEMBL2581 | P07339 | Cathepsin D | 95.57% | 98.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.38% | 94.45% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 95.23% | 89.23% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 95.20% | 83.65% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 95.16% | 89.00% |
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 | 95.12% | 91.83% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 93.86% | 80.00% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 93.76% | 88.00% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 93.50% | 87.16% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.32% | 95.89% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 93.07% | 81.58% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 92.44% | 93.99% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 92.42% | 91.79% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 92.36% | 96.47% |
| CHEMBL4237 | O75582 | Ribosomal protein S6 kinase alpha 5 | 91.69% | 91.00% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 91.49% | 90.95% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 91.46% | 90.08% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 91.29% | 94.00% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 91.25% | 91.96% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 90.96% | 96.00% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 90.92% | 95.83% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 89.92% | 91.03% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 89.43% | 96.00% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 89.17% | 93.03% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 88.13% | 98.59% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.01% | 97.09% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 86.94% | 99.23% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.62% | 86.33% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 86.32% | 97.14% |
| CHEMBL6167 | O95835 | Serine/threonine-protein kinase LATS1 | 86.19% | 98.33% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 84.74% | 91.07% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 84.30% | 97.79% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 84.19% | 82.50% |
| CHEMBL2527 | O96017 | Serine/threonine-protein kinase Chk2 | 83.83% | 97.50% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.27% | 93.00% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 81.98% | 85.30% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 81.72% | 82.86% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.41% | 88.56% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 80.25% | 95.36% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10480397 |
| LOTUS | LTS0134876 |
| wikiData | Q105013029 |